Facebook
Twitter
LinkedIn
ForwardBiosimilars: Updated Market Landscape
This activity will improve pharmacist understanding of the approval and management of biosimilar products. This education will ensure that all members of the healthcare team involved in the medication process are aware of current best practices. This is especially important as pharmacy interacts with medicine in relation to prescribing biosimilars.
Target Audience
Pharmacist
Learning Objectives
Describe new guidance on biosimilars and biosimilar interchangeability
Review biosimilars currently available on the market
Identify upcoming biosimilars in the specialty pipeline
Additional Information
| Attachment | Size |
|---|---|
 Biosimilar CE Outline_Pharmacy (1).docx | 15.76 KB |
This activity will improve pharmacist understanding of the approval and management of biosimilar products. This education will ensure that all members of the healthcare team involved in the medication process are aware of current best practices. This is especially important as pharmacy interacts with medicine in relation to prescribing biosimilars.
Hannah Rapp, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 Attendance